{"product_id":"trelegy-ellipta-powder-for-inhalation","title":"Trelegy Ellipta Powder for inhalation","description":"\u003ch3\u003e\u003cspan style=\"font-size: 16px;\"\u003eDrug Description for Trelegy Ellipta\u003c\/span\u003e\u003c\/h3\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eProduct Name:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eTrelegy Ellipta\u003c\/span\u003e\u003c\/p\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eDrug Class and Categories:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eDrug Class:\u003c\/strong\u003e Respiratory Agents, Combination\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eCategories:\u003c\/strong\u003e Long-Acting Beta2-Agonists (LABA), Inhaled Corticosteroids (ICS), Long-Acting Muscarinic Antagonists (LAMA)\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eActive Ingredient:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eFluticasone Furoate (Inhaled Corticosteroid)\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eUmeclidinium (Long-Acting Muscarinic Antagonist)\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eVilanterol (Long-Acting Beta2-Agonist)\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eOther Names:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eTrelegy\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eMode of Action:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eTrelegy Ellipta combines three medications in one inhaler to provide comprehensive management of chronic obstructive pulmonary disease (COPD) and asthma. Fluticasone furoate reduces inflammation in the lungs, umeclidinium relaxes airway muscles to open airways, and vilanterol relaxes bronchial muscles to ease breathing. Together, they improve lung function and reduce COPD exacerbations.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eHow to Use:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eUse Trelegy Ellipta exactly as prescribed by your healthcare provider.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eInhale once daily at the same time each day.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eFollow the instructions for using the Ellipta inhaler properly to ensure you receive the correct dose.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eRecommended Dosage:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eAdults with COPD or Asthma:\u003c\/strong\u003e One inhalation once daily, preferably at the same time each day.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eDirections:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eOpen the cover of the inhaler and slide down the mouthpiece cover until you hear a click.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eExhale fully before placing the mouthpiece in your mouth.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eInhale the medication deeply and hold your breath for about 10 seconds.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eExhale slowly and close the mouthpiece cover until it clicks into place.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eCautions:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eDo not use Trelegy Ellipta to treat acute bronchospasm or asthma attacks.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eInform your healthcare provider of any allergies, especially to fluticasone, umeclidinium, or vilanterol.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eLong-term use may increase the risk of pneumonia in patients with COPD.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eRegular monitoring of lung function is recommended.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eGuidelines:\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cul\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eRinse your mouth with water without swallowing after using the inhaler to reduce the risk of oral thrush.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eStore Trelegy Ellipta at room temperature, away from moisture and heat.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eKeep the inhaler out of reach of children.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003cli\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eDiscard the inhaler 6 weeks after opening or when the dose counter reads \"0,\" whichever comes first.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch4\u003e\u003cspan style=\"font-size: 16px;\"\u003eFrequently Asked Questions (FAQs):\u003c\/span\u003e\u003c\/h4\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: What should I do if I miss a dose of Trelegy Ellipta?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e A: If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at once to make up for a missed dose.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: Can Trelegy Ellipta be used to treat asthma?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: Yes, Trelegy Ellipta is approved for the treatment of asthma in adults who require a combination of an inhaled corticosteroid, a long-acting muscarinic antagonist, and a long-acting beta2-agonist.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: What are the common side effects of Trelegy Ellipta?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: Common side effects include upper respiratory tract infections, headache, back pain, and oral thrush. Contact your healthcare provider if these effects persist or worsen.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: Can I use Trelegy Ellipta with other medications?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: Some medications can interact with Trelegy Ellipta. Inform your healthcare provider about all the medications and supplements you are taking.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: Is Trelegy Ellipta safe during pregnancy?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: The safety of Trelegy Ellipta during pregnancy is not well established. If you are pregnant or planning to become pregnant, consult your healthcare provider to weigh the potential benefits and risks.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: How should I store Trelegy Ellipta?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: Store at room temperature, away from moisture and heat. Keep the inhaler in its sealed tray until ready for use.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: How long does it take for Trelegy Ellipta to start working?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: Some patients may experience an improvement in breathing within 24 hours, but it may take several days to experience the full benefits of the medication.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: Can I use Trelegy Ellipta for an asthma attack?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: No, Trelegy Ellipta is not intended for the relief of acute bronchospasm or asthma attacks. Use a rescue inhaler for sudden breathing problems.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: How often should I use Trelegy Ellipta?\u003c\/strong\u003e \u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eA: Use Trelegy Ellipta once daily, at the same time each day. Do not use it more than once every 24 hours.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e\u003cstrong\u003eQ: What if I experience severe side effects while using Trelegy Ellipta?\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003e A: Seek immediate medical attention if you experience symptoms such as severe allergic reactions, difficulty breathing, or severe chest pain.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003cp\u003e\u003cspan style=\"font-size: 16px;\"\u003eBy following these guidelines and using Trelegy Ellipta as prescribed, you can effectively manage COPD or asthma and maintain your respiratory health. Always consult your healthcare provider for personalized advice and information.\u003c\/span\u003e\u003c\/p\u003e\r\n\u003ch3 data-start=\"275\" data-end=\"305\"\u003eWhat is Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"306\" data-end=\"526\"\u003e\u003cstrong data-start=\"306\" data-end=\"325\"\u003eTrelegy Ellipta\u003c\/strong\u003e is a once‑daily, triple‑therapy inhaler approved for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and, in some regions, for asthma. It combines three active ingredients:\u003c\/p\u003e\r\n\u003cul data-start=\"527\" data-end=\"855\"\u003e\r\n\u003cli data-start=\"527\" data-end=\"621\"\u003e\n\u003cstrong data-start=\"529\" data-end=\"553\"\u003eFluticasone Furoate:\u003c\/strong\u003e An inhaled corticosteroid (ICS) that reduces airway inflammation.\u003c\/li\u003e\r\n\u003cli data-start=\"622\" data-end=\"754\"\u003e\n\u003cstrong data-start=\"624\" data-end=\"641\"\u003eUmeclidinium:\u003c\/strong\u003e A long‑acting muscarinic antagonist (LAMA) that relaxes airway smooth muscle by blocking muscarinic receptors.\u003c\/li\u003e\r\n\u003cli data-start=\"755\" data-end=\"855\"\u003e\n\u003cstrong data-start=\"757\" data-end=\"772\"\u003eVilanterol:\u003c\/strong\u003e A long‑acting beta‑agonist (LABA) that induces bronchodilation to improve airflow.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"857\" data-end=\"973\"\u003e\u003cem data-start=\"857\" data-end=\"973\"\u003eReference: U.S. Food and Drug Administration (FDA) prescribing information; ClinicalTrials.gov (e.g., NCT02222720)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"975\" data-end=\"978\"\u003e\r\n\u003ch3 data-start=\"980\" data-end=\"1039\"\u003eWhat are the other popular names for Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"1040\" data-end=\"1278\"\u003eTrelegy Ellipta is primarily known by its brand name \u003cstrong data-start=\"1093\" data-end=\"1112\"\u003eTrelegy Ellipta\u003c\/strong\u003e. It is sometimes referred to simply as \u003cstrong data-start=\"1152\" data-end=\"1163\"\u003eTrelegy\u003c\/strong\u003e in clinical and patient communications. Its individual components are widely recognized under their generic names.\u003c\/p\u003e\r\n\u003cp data-start=\"1280\" data-end=\"1357\"\u003e\u003cem data-start=\"1280\" data-end=\"1357\"\u003eReference: U.S. FDA; National Institutes of Health (NIH) clinical resources\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1359\" data-end=\"1362\"\u003e\r\n\u003ch3 data-start=\"1364\" data-end=\"1421\"\u003eWhat is the drug classification of Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"1422\" data-end=\"1695\"\u003eTrelegy Ellipta is classified as a \u003cstrong data-start=\"1457\" data-end=\"1491\"\u003ecombination inhaled medication\u003c\/strong\u003e for respiratory diseases. It falls under the therapeutic category of \u003cstrong data-start=\"1561\" data-end=\"1588\"\u003etriple therapy for COPD\u003c\/strong\u003e, combining an inhaled corticosteroid, a long‑acting muscarinic antagonist, and a long‑acting beta‑agonist.\u003c\/p\u003e\r\n\u003cp data-start=\"1697\" data-end=\"1757\"\u003e\u003cem data-start=\"1697\" data-end=\"1757\"\u003eReference: American Thoracic Society (ATS) guidelines; FDA\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"1759\" data-end=\"1762\"\u003e\r\n\u003ch3 data-start=\"1764\" data-end=\"1816\"\u003eWhat is the mode of action of Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"1817\" data-end=\"1900\"\u003eTrelegy Ellipta works via a synergistic mechanism involving its three components:\u003c\/p\u003e\r\n\u003cul data-start=\"1901\" data-end=\"2378\"\u003e\r\n\u003cli data-start=\"1901\" data-end=\"1996\"\u003e\n\u003cstrong data-start=\"1903\" data-end=\"1933\"\u003eFluticasone Furoate (ICS):\u003c\/strong\u003e Reduces airway inflammation and helps prevent exacerbations.\u003c\/li\u003e\r\n\u003cli data-start=\"1997\" data-end=\"2136\"\u003e\n\u003cstrong data-start=\"1999\" data-end=\"2023\"\u003eUmeclidinium (LAMA):\u003c\/strong\u003e Blocks muscarinic receptors, leading to relaxation of airway smooth muscles and decreased bronchoconstriction.\u003c\/li\u003e\r\n\u003cli data-start=\"2137\" data-end=\"2378\"\u003e\n\u003cstrong data-start=\"2139\" data-end=\"2161\"\u003eVilanterol (LABA):\u003c\/strong\u003e Stimulates beta2‑adrenergic receptors, promoting bronchodilation and improved airflow.\u003cbr data-start=\"2248\" data-end=\"2251\"\u003eTogether, these actions enhance lung function, reduce symptoms, and lower the frequency of exacerbations in patients with COPD.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2380\" data-end=\"2461\"\u003e\u003cem data-start=\"2380\" data-end=\"2461\"\u003eReference: New England Journal of Medicine (NEJM); U.S. FDA; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2463\" data-end=\"2466\"\u003e\r\n\u003ch3 data-start=\"2468\" data-end=\"2502\"\u003eHow is Trelegy Ellipta used?\u003c\/h3\u003e\r\n\u003cp data-start=\"2503\" data-end=\"2868\"\u003eTrelegy Ellipta is indicated for the long‑term maintenance treatment of patients with COPD to reduce the risk of moderate to severe exacerbations and improve lung function. In some regions, it is also approved for asthma maintenance in patients who require both an ICS and long‑acting bronchodilator therapy. It is not intended for the relief of acute bronchospasm.\u003c\/p\u003e\r\n\u003cp data-start=\"2870\" data-end=\"2935\"\u003e\u003cem data-start=\"2870\" data-end=\"2935\"\u003eReference: U.S. FDA; American Thoracic Society (ATS) guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"2937\" data-end=\"2940\"\u003e\r\n\u003ch3 data-start=\"2942\" data-end=\"3018\"\u003eWhat is the recommended dosage and administration for Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cul data-start=\"3019\" data-end=\"3470\"\u003e\r\n\u003cli data-start=\"3019\" data-end=\"3300\"\u003e\n\u003cstrong data-start=\"3021\" data-end=\"3032\"\u003eDosage:\u003c\/strong\u003e The standard regimen is \u003cstrong data-start=\"3057\" data-end=\"3086\"\u003eone inhalation once daily\u003c\/strong\u003e. The inhaler delivers a fixed dose of the three active ingredients (approximately 100 mcg fluticasone furoate, 62.5 mcg umeclidinium, and 25 mcg vilanterol), although exact dosing may vary by regional approvals.\u003c\/li\u003e\r\n\u003cli data-start=\"3301\" data-end=\"3470\"\u003e\n\u003cstrong data-start=\"3303\" data-end=\"3322\"\u003eAdministration:\u003c\/strong\u003e\r\n\u003cul data-start=\"3327\" data-end=\"3470\"\u003e\r\n\u003cli data-start=\"3327\" data-end=\"3392\"\u003eUse the Ellipta inhaler once daily at the same time each day.\u003c\/li\u003e\r\n\u003cli data-start=\"3395\" data-end=\"3470\"\u003eRinse your mouth after inhalation to reduce the risk of oral candidiasis.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3472\" data-end=\"3533\"\u003e\u003cem data-start=\"3472\" data-end=\"3533\"\u003eReference: U.S. FDA; ClinicalTrials.gov (e.g., NCT02222720)\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"3535\" data-end=\"3538\"\u003e\r\n\u003ch3 data-start=\"3540\" data-end=\"3608\"\u003eWhat prescribing information is important for Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cul data-start=\"3609\" data-end=\"4351\"\u003e\r\n\u003cli data-start=\"3609\" data-end=\"3721\"\u003e\n\u003cstrong data-start=\"3611\" data-end=\"3627\"\u003eIndications:\u003c\/strong\u003e Approved for maintenance treatment in patients with COPD (and in some regions, for asthma).\u003c\/li\u003e\r\n\u003cli data-start=\"3722\" data-end=\"3937\"\u003e\n\u003cstrong data-start=\"3724\" data-end=\"3746\"\u003eContraindications:\u003c\/strong\u003e\r\n\u003cul data-start=\"3751\" data-end=\"3937\"\u003e\r\n\u003cli data-start=\"3751\" data-end=\"3836\"\u003eNot for use in patients with acute episodes of bronchospasm or as rescue therapy.\u003c\/li\u003e\r\n\u003cli data-start=\"3839\" data-end=\"3937\"\u003eContraindicated in patients with a known hypersensitivity to any component of the formulation.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"3938\" data-end=\"4202\"\u003e\n\u003cstrong data-start=\"3940\" data-end=\"3955\"\u003eMonitoring:\u003c\/strong\u003e\r\n\u003cul data-start=\"3960\" data-end=\"4202\"\u003e\r\n\u003cli data-start=\"3960\" data-end=\"4035\"\u003eRegular assessment of lung function and symptom control is recommended.\u003c\/li\u003e\r\n\u003cli data-start=\"4038\" data-end=\"4202\"\u003ePeriodic monitoring for potential side effects such as pneumonia or adrenal suppression is advised, especially in patients with a history of recurrent infections.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4203\" data-end=\"4351\"\u003e\n\u003cstrong data-start=\"4205\" data-end=\"4232\"\u003eSpecial Considerations:\u003c\/strong\u003e\r\n\u003cul data-start=\"4237\" data-end=\"4351\"\u003e\r\n\u003cli data-start=\"4237\" data-end=\"4297\"\u003ePatients should be educated on proper inhaler technique.\u003c\/li\u003e\r\n\u003cli data-start=\"4300\" data-end=\"4351\"\u003eIt is not for immediate relief of acute symptoms.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4353\" data-end=\"4454\"\u003e\u003cem data-start=\"4353\" data-end=\"4454\"\u003eReference: U.S. FDA prescribing information; National Institutes of Health (NIH) clinical resources\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"4456\" data-end=\"4459\"\u003e\r\n\u003ch3 data-start=\"4461\" data-end=\"4551\"\u003eWhat safety information, warnings, and cautions are associated with Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cul data-start=\"4552\" data-end=\"5402\"\u003e\r\n\u003cli data-start=\"4552\" data-end=\"4697\"\u003e\n\u003cstrong data-start=\"4554\" data-end=\"4578\"\u003eCommon Side Effects:\u003c\/strong\u003e\r\n\u003cul data-start=\"4583\" data-end=\"4697\"\u003e\r\n\u003cli data-start=\"4583\" data-end=\"4612\"\u003eThrush (oral candidiasis)\u003c\/li\u003e\r\n\u003cli data-start=\"4615\" data-end=\"4629\"\u003eHoarseness\u003c\/li\u003e\r\n\u003cli data-start=\"4632\" data-end=\"4670\"\u003eUpper respiratory tract infections\u003c\/li\u003e\r\n\u003cli data-start=\"4673\" data-end=\"4685\"\u003eHeadache\u003c\/li\u003e\r\n\u003cli data-start=\"4688\" data-end=\"4697\"\u003eCough\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"4698\" data-end=\"5148\"\u003e\n\u003cstrong data-start=\"4700\" data-end=\"4724\"\u003eWarnings \u0026amp; Cautions:\u003c\/strong\u003e\r\n\u003cul data-start=\"4729\" data-end=\"5148\"\u003e\r\n\u003cli data-start=\"4729\" data-end=\"4829\"\u003e\n\u003cstrong data-start=\"4731\" data-end=\"4750\"\u003ePneumonia Risk:\u003c\/strong\u003e Inhaled corticosteroids can increase the risk of pneumonia in COPD patients.\u003c\/li\u003e\r\n\u003cli data-start=\"4832\" data-end=\"4936\"\u003e\n\u003cstrong data-start=\"4834\" data-end=\"4858\"\u003eAdrenal Suppression:\u003c\/strong\u003e Long-term ICS use may suppress adrenal function; monitor if symptoms arise.\u003c\/li\u003e\r\n\u003cli data-start=\"4939\" data-end=\"5035\"\u003e\n\u003cstrong data-start=\"4941\" data-end=\"4959\"\u003eLocal Effects:\u003c\/strong\u003e Rinse mouth after use to minimize local side effects such as oral thrush.\u003c\/li\u003e\r\n\u003cli data-start=\"5038\" data-end=\"5148\"\u003e\n\u003cstrong data-start=\"5040\" data-end=\"5061\"\u003eSystemic Effects:\u003c\/strong\u003e Although the systemic absorption is low, monitor for potential cardiovascular effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003cli data-start=\"5149\" data-end=\"5402\"\u003e\n\u003cstrong data-start=\"5151\" data-end=\"5173\"\u003eDrug Interactions:\u003c\/strong\u003e\r\n\u003cul data-start=\"5178\" data-end=\"5402\"\u003e\r\n\u003cli data-start=\"5178\" data-end=\"5252\"\u003e\n\u003cstrong data-start=\"5180\" data-end=\"5198\"\u003eBeta‑Blockers:\u003c\/strong\u003e May reduce the bronchodilator effect of vilanterol.\u003c\/li\u003e\r\n\u003cli data-start=\"5255\" data-end=\"5402\"\u003e\n\u003cstrong data-start=\"5257\" data-end=\"5291\"\u003eOther Respiratory Medications:\u003c\/strong\u003e Concomitant use with other inhaled therapies should be managed to avoid duplicative effects or adverse events.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5404\" data-end=\"5489\"\u003e\u003cem data-start=\"5404\" data-end=\"5489\"\u003eReference: U.S. FDA; American Thoracic Society (ATS) guidelines; ClinicalTrials.gov\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"5491\" data-end=\"5494\"\u003e\r\n\u003ch3 data-start=\"5496\" data-end=\"5567\"\u003eWhat drug interactions should be considered with Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cul data-start=\"5568\" data-end=\"5982\"\u003e\r\n\u003cli data-start=\"5568\" data-end=\"5683\"\u003e\n\u003cstrong data-start=\"5570\" data-end=\"5588\"\u003eBeta‑Blockers:\u003c\/strong\u003e Non‑selective beta‑blockers may diminish the bronchodilator response provided by vilanterol.\u003c\/li\u003e\r\n\u003cli data-start=\"5684\" data-end=\"5818\"\u003e\n\u003cstrong data-start=\"5686\" data-end=\"5716\"\u003eOther Inhaled Medications:\u003c\/strong\u003e Use caution when combining with other long‑acting bronchodilators to prevent additive side effects.\u003c\/li\u003e\r\n\u003cli data-start=\"5819\" data-end=\"5982\"\u003e\n\u003cstrong data-start=\"5821\" data-end=\"5850\"\u003eSystemic Corticosteroids:\u003c\/strong\u003e Caution is advised if additional systemic corticosteroid therapy is needed, as this may increase the risk of systemic side effects.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5984\" data-end=\"6062\"\u003e\u003cem data-start=\"5984\" data-end=\"6062\"\u003eReference: U.S. FDA; National Institutes of Health (NIH) clinical guidelines\u003c\/em\u003e\u003c\/p\u003e\r\n\u003chr data-start=\"6064\" data-end=\"6067\"\u003e\r\n\u003ch3 data-start=\"6069\" data-end=\"6168\"\u003eWhere can I find additional clinical evidence and detailed information about Trelegy Ellipta?\u003c\/h3\u003e\r\n\u003cp data-start=\"6169\" data-end=\"6267\"\u003eFor more detailed clinical data, dosing guidelines, and safety monitoring information, refer to:\u003c\/p\u003e\r\n\u003cul data-start=\"6268\" data-end=\"6667\"\u003e\r\n\u003cli data-start=\"6268\" data-end=\"6356\"\u003e\n\u003cstrong data-start=\"6270\" data-end=\"6322\"\u003eU.S. Food and Drug Administration (FDA) Website:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.fda.gov\/\" target=\"_new\" rel=\"noopener\" data-start=\"6323\" data-end=\"6354\"\u003eFDA.gov\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003cli data-start=\"6357\" data-end=\"6448\"\u003e\n\u003cstrong data-start=\"6359\" data-end=\"6382\"\u003eClinicalTrials.gov:\u003c\/strong\u003e Search for trials involving Trelegy Ellipta (e.g., NCT02164513)\u003c\/li\u003e\r\n\u003cli data-start=\"6449\" data-end=\"6580\"\u003e\n\u003cstrong data-start=\"6451\" data-end=\"6526\"\u003eNew England Journal of Medicine (NEJM) and Lancet Respiratory Medicine:\u003c\/strong\u003e For peer‑reviewed studies on triple therapy in COPD\u003c\/li\u003e\r\n\u003cli data-start=\"6581\" data-end=\"6667\"\u003e\n\u003cstrong data-start=\"6583\" data-end=\"6630\"\u003eAmerican Thoracic Society (ATS) Guidelines:\u003c\/strong\u003e \u003ca href=\"https:\/\/www.thoracic.org\/\" target=\"_new\" rel=\"noopener\" data-start=\"6631\" data-end=\"6667\"\u003eATS.org\u003c\/a\u003e\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003chr data-start=\"6669\" data-end=\"6672\"\u003e\r\n\u003ch3 data-start=\"6674\" data-end=\"6694\"\u003eFinal Thoughts\u003c\/h3\u003e\r\n\u003cp data-start=\"6695\" data-end=\"7350\"\u003e\u003cstrong data-start=\"6695\" data-end=\"6714\"\u003eTrelegy Ellipta\u003c\/strong\u003e represents a significant advancement in the management of chronic obstructive pulmonary disease (and, in some regions, asthma) by combining three complementary mechanisms of action in a single, once‑daily inhaler. Through the anti‑inflammatory effects of fluticasone furoate, the bronchodilatory action of vilanterol, and the anticholinergic effects of umeclidinium, Trelegy Ellipta improves lung function, reduces exacerbations, and enhances quality of life for patients with COPD. Given the potential risks—such as pneumonia and adrenal suppression—its use should be carefully monitored, and proper inhaler technique must be ensured.\u003c\/p\u003e\r\n\u003cp data-start=\"7352\" data-end=\"7576\"\u003e\u003cem data-start=\"7352\" data-end=\"7576\"\u003eDisclaimer: This information is provided for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider before initiating or modifying any medication regimen.\u003c\/em\u003e\u003c\/p\u003e","brand":"EZ Chemist","offers":[{"title":"100mcg\/62.5mcg\/25mcg","offer_id":51735706272027,"sku":"Trelegy Ellipta Powder for inhalation (100mcg\/62.5mcg\/25mcg)","price":117.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0992\/3303\/8619\/files\/trelegy_ellipta_100_62.5_25_mcg_inhalation_powd006f1271-0614-4464-a9a6-aa5c00a021ce.gif?v=1770407365","url":"https:\/\/ezchemist.com\/products\/trelegy-ellipta-powder-for-inhalation","provider":"EZ Chemist","version":"1.0","type":"link"}